Passage-dependent accumulation of somatic mutations in mesenchymal stromal cells during in vitro culture revealed by whole genome sequencing

[1]  R. Handsaker,et al.  Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations , 2017, Nature.

[2]  Kristopher L. Nazor,et al.  Whole-genome mutational burden analysis of three pluripotency induction methods , 2016, Nature Communications.

[3]  K. Tarte,et al.  Hypoxia Differentially Modulates the Genomic Stability of Clinical‐Grade ADSCs and BM‐MSCs in Long‐Term Culture , 2015, Stem cells.

[4]  TorreMaria Luisa,et al.  Ex Vivo Expanded Mesenchymal Stromal Cell Minimal Quality Requirements for Clinical Application , 2015 .

[5]  Kyung-Chul Choi,et al.  Deubiquitinase OTUD5 mediates the sequential activation of PDCD5 and p53 in response to genotoxic stress. , 2015, Cancer letters.

[6]  Mingming Jia,et al.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..

[7]  G. Alessandri,et al.  Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application. , 2015, Stem cells and development.

[8]  Linzhao Cheng,et al.  Whole-Genome Sequencing Identifies Genetic Variances in Culture-Expanded Human Mesenchymal Stem Cells , 2014, Stem cell reports.

[9]  Allison Hubel,et al.  Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices , 2014, Transfusion.

[10]  Yang Wang,et al.  Long-term cultured mesenchymal stem cells frequently develop genomic mutations but do not undergo malignant transformation , 2013, Cell Death and Disease.

[11]  Mauricio O. Carneiro,et al.  From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.

[12]  Xu Cao,et al.  The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine , 2013, Nature Medicine.

[13]  E. Lombardo,et al.  Mesenchymal stem cells as therapeutic agents of inflammatory and autoimmune diseases. , 2012, Current opinion in biotechnology.

[14]  Yutao Du,et al.  Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. , 2012, Cell stem cell.

[15]  Christopher A. Miller,et al.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.

[16]  E. Kirkness,et al.  Somatic coding mutations in human induced pluripotent stem cells , 2011, Nature.

[17]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[18]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[19]  V. Goldberg,et al.  Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. , 2010, Tissue engineering. Part A.

[20]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[21]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[22]  E. Pietras,et al.  A Deubiquitinase That Regulates Type I Interferon Production , 2007, Science.

[23]  Joseph T. Glessner,et al.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.

[24]  A. Cometa,et al.  Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms , 2010 .

[25]  N. Samani,et al.  Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study , 2007, The Lancet.

[26]  F. Claas,et al.  Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta , 2004, Stem cells.

[27]  M. Wigler,et al.  Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.

[28]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[29]  C. Waller,et al.  Lack of telomerase activity in human mesenchymal stem cells , 2003, Leukemia.

[30]  Min Zhu,et al.  Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.

[31]  R. Cawthon.  Telomere measurement by quantitative PCR. , 2002, Nucleic acids research.

[32]  M. Mastrogiacomo,et al.  Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. , 2000, Experimental hematology.

[33]  R. Class,et al.  Propagation and senescence of human marrow stromal cells in culture: a simple colony‐forming assay identifies samples with the greatest potential to propagate and differentiate , 1999, British journal of haematology.

[34]  A. Friedenstein,et al.  Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. , 1968, Transplantation.